BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32630356)

  • 1. Interaction between Mesocortical and Mesothalamic Catecholaminergic Transmissions Associated with NMDA Receptor in the Locus Coeruleus.
    Okada M; Fukuyama K
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic Administrations of Guanfacine on Mesocortical Catecholaminergic and Thalamocortical Glutamatergic Transmissions.
    Fukuyama K; Nakano T; Shiroyama T; Okada M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Discrimination of Effects of MK801 on Thalamocortical, Mesothalamic, and Mesocortical Transmissions.
    Okada M; Fukuyama K; Nakano T; Ueda Y
    Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31752219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of acute and sub-chronic administrations of guanfacine on catecholaminergic transmissions in the orbitofrontal cortex.
    Okada M; Fukuyama K; Kawano Y; Shiroyama T; Suzuki D; Ueda Y
    Neuropharmacology; 2019 Sep; 156():107547. PubMed ID: 30802458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine protects thalamocortical hyper-glutamatergic transmission induced by NMDA receptor antagonism via activation of system xc.
    Okada M; Fukuyama K; Kawano Y; Shiroyama T; Ueda Y
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00457. PubMed ID: 30784207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between orexinergic neurons and NMDA receptors in the control of locus coeruleus-cerebrocortical noradrenergic activity of the rat.
    Tose R; Kushikata T; Yoshida H; Kudo M; Furukawa K; Ueno S; Hirota K
    Brain Res; 2009 Jan; 1250():81-7. PubMed ID: 19007758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clozapine Normalizes a Glutamatergic Transmission Abnormality Induced by an Impaired NMDA Receptor in the Thalamocortical Pathway via the Activation of a Group III Metabotropic Glutamate Receptor.
    Fukuyama K; Kato R; Murata M; Shiroyama T; Okada M
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31213006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lurasidone inhibits NMDA receptor antagonist-induced functional abnormality of thalamocortical glutamatergic transmission via 5-HT
    Okada M; Fukuyama K; Ueda Y
    Br J Pharmacol; 2019 Oct; 176(20):4002-4018. PubMed ID: 31347694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal.
    Rasmussen K; Fuller RW; Stockton ME; Perry KW; Swinford RM; Ornstein PL
    Eur J Pharmacol; 1991 May; 197(1):9-16. PubMed ID: 1832640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystine/Glutamate Antiporter and Aripiprazole Compensate NMDA Antagonist-Induced Dysfunction of Thalamocortical L-Glutamatergic Transmission.
    Fukuyama K; Hasegawa T; Okada M
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single dose of cocaine potentiates glutamatergic synaptic transmission onto locus coeruleus neurons.
    Zhu F; Wu Q; Li J; Grycel K; Liu B; Sun X; Zhou L; Jiao R; Song R; Khan YM; Wang Q; Wang L; Xu Y; Li J; Zhang B; Zhou Z
    Cell Calcium; 2017 Nov; 67():11-20. PubMed ID: 29029785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The noradrenaline-dopamine interaction in the rat medial prefrontal cortex studied by multi-probe microdialysis.
    Kawahara H; Kawahara Y; Westerink BH
    Eur J Pharmacol; 2001 Apr; 418(3):177-86. PubMed ID: 11343687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor.
    Okada M; Matsumoto R; Yamamoto Y; Fukuyama K
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33572981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noradrenergic inputs from locus coeruleus to posterior ventral tegmental area are essential to support ethanol reinforcement.
    Shelkar GP; Kumar S; Singru PS; Subhedar NK; Kokare DM
    Addict Biol; 2017 Mar; 22(2):291-302. PubMed ID: 26549324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic fluoxetine reverses the effects of chronic corticosterone treatment on α
    Horrillo I; Ortega JE; Diez-Alarcia R; Urigüen L; Meana JJ
    Neuropharmacology; 2019 Nov; 158():107731. PubMed ID: 31376424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective enhancement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia.
    Masana M; Bortolozzi A; Artigas F
    Int J Neuropsychopharmacol; 2011 Feb; 14(1):53-68. PubMed ID: 20701825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective distribution of the NMDA-R1 glutamate receptor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat brain: an immunoelectron microscopic study.
    Van Bockstaele EJ; Colago EE
    J Comp Neurol; 1996 Jun; 369(4):483-96. PubMed ID: 8761923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced L-β-Aminoisobutyric Acid Is Involved in the Pathophysiology of Effectiveness for Treatment-Resistant Schizophrenia and Adverse Reactions of Clozapine.
    Fukuyama K; Motomura E; Okada M
    Biomolecules; 2023 May; 13(5):. PubMed ID: 37238731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat--II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function.
    Morari M; O'Connor WT; Ungerstedt U; Bianchi C; Fuxe K
    Neuroscience; 1996 May; 72(1):89-97. PubMed ID: 8730708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histamine in the locus coeruleus promotes descending noradrenergic inhibition of neuropathic hypersensitivity.
    Wei H; Jin CY; Viisanen H; You HJ; Pertovaara A
    Pharmacol Res; 2014 Dec; 90():58-66. PubMed ID: 25304183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.